Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Fuji
Medtronic
AstraZeneca
McKinsey
Dow
US Army
Chinese Patent Office
Chubb

Generated: June 25, 2018

DrugPatentWatch Database Preview

ARDUAN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Arduan patents expire, and when can generic versions of Arduan launch?

Arduan is a drug marketed by Organon Usa Inc and is included in one NDA.

The generic ingredient in ARDUAN is pipecuronium bromide. There is one drug master file entry for this compound. Additional details are available on the pipecuronium bromide profile page.
Summary for ARDUAN
Drug patent expirations by year for ARDUAN
Medical Subject Heading (MeSH) Categories for ARDUAN
Synonyms for ARDUAN
(2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2,16-bis(4,4-dimethylpiperazin-4-ium-1-yl)androstane dibromide
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-2,16-bis(4,4-dimethylpiperazin-4-ium-1-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate dibromide
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-2,16-bis(4,4-dimethylpiperazin-4-ium-1-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate dibromide
4-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-5,14-BIS(ACETYLOXY)-13-(4,4-DIMETHYLPIPERAZIN-4-IUM-1-YL)-2,15-DIMETHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECAN-4-YL]-1,1-DIMETHYLPIPERAZIN-1-IUM DIBROMIDE
4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-Bis(acetoxy)androstane-2,16-diyl)bis(1,1-dimethylpiperazinium) dibromide
4,4'-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3,17-diacetoxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-2,16-diyl)bis(1,1-dimethylpiperazin-1-ium) bromide
4,4'-(3alpha,17beta-Dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis(1,1-dimethylpiperazinium)dibromide, diacetate (ester)
52212-02-9
67880-85-7
68399-58-6 (Parent)
84307-15-3
AC1L232J
AN-15610
Arduan (TN)
BC222602
C35H62N4O4
C35H62N4O4.2Br
CAS-52212-02-9
CHEBI:8231
CHEMBL1200722
D00764
DSSTox_CID_3478
DSSTox_GSID_23478
DSSTox_RID_77044
DTXSID8023478
EINECS 257-740-4
KS-1465
LS-113699
MolPort-006-129-706
NCGC00182708-01
Pipecurium bromide
Pipecuronio bromuro [Spanish]
PIPECURONIUM BROMIDE
Pipecuronium bromide [USAN:INN:BAN]
Piperazinium, 4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-, dibromide
Piperazinium, 4,4'-(3,17-dihydroxyandrostan-2,16-diyl)bis(1,1-dimethyl-, dibromide, diacetate
Piperazinium, 4,4'-(3,17-dihydroxyandrostan-2,16-diyl)bis(1,1-dimethyl-, dibromide,diacetate
PL058374
Q-101016
R6ZTY81RE1
RGH 1106
RGH-1106
SCHEMBL42154
Tox21_113014
UNII-R6ZTY81RE1

US Patents and Regulatory Information for ARDUAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc ARDUAN pipecuronium bromide INJECTABLE;INJECTION 019638-001 Jun 26, 1990 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Chinese Patent Office
Colorcon
Express Scripts
US Department of Justice
Harvard Business School
Baxter
Daiichi Sankyo
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.